Financing: Page 3

BARDA commits $30.5M to the development of musculoskeletal imaging system
By Nick Paul Taylor
BARDA has committed funding to support the development of a device that could quickly triage fracture severity in the wake of a chemical, biological, radiological, or nuclear attack and thereby preserve x-ray resources for the highest-priority patients.
August 11, 2023
Research Money Social
CareDx reports 13% second-quarter revenue decrease from previous year
By LabPulse.com staff writers
The company expects full-year 2023 revenues to be in the range of $240 million to $260 million.
August 9, 2023
Graph Financial Results Tablet Social
Co-Diagnostics awarded over $2M from Bill & Melinda Gates Foundation for TB and HPV tests
By Matt Limb
Dwight Egan, CEO of Co-Diagnostics, said the grants would help support the worldwide effort to prevent the spread of both TB and HPV in countries where they have been endemic killers for generations.
July 26, 2023
Bacteria Mycobacterium Tuberculosis Social
Biotech firm AltPep closes $53M Series B financing round
By LabPulse.com staff writers
AltPep said that the proceeds from the round will be used to accelerate its Sobin therapeutics for Alzheimer’s and Parkinson’s diseases into phase I clinical trials, as well as to advance its Soba diagnostic blood-based assay for Alzheimer’s disease.
June 23, 2023
Research Money Social
Infectious disease NGS test developer Delve Bio closes $35M Series A financing
By LabPulse.com staff writers
The company’s mNGS-based infectious disease testing platform uses technology developed at the University of California San Francisco Center for Next-Gen Precision Diagnostics.
June 20, 2023
Sequencing Dna Rna Social
Capitainer secures $5.7M to advance self-sampling technology
By LabPulse.com staff writers
Capitainer will use the funding to increase production capacity, develop new products, and intensify sales and marketing efforts.
May 11, 2023
Money Bag Grant Award Social
OpGen prices $3.5M public stock offering
By LabPulse.com staff writers
Gross proceeds of the offering, before the deduction of the placement agent’s fees and other expenses, are expected to be $3.5 million, the firm said.
May 2, 2023
Business Graph Money Stocks Social
Pattern Bioscience raises $28.7M in Series C financing to develop, commercialize rapid test platform for infectious diseases
By LabPulse.com staff writers
Pattern Bioscience said it will use the funds to complete the development of its infectious disease diagnostic platform, perform validation studies, and submit data for the platform and the company’s initial test for pneumonia for FDA review.
April 27, 2023
Computer Brain Money Social
CND Life Sciences closes $4.5M seed financing round
By LabPulse.com staff writers
The funding is intended to accelerate the commercialization of the Syn-One test that identifies abnormal alpha-synuclein aggregation in cutaneous nerves through a skin biopsy.
April 6, 2023
Research Money Social
Alzheimer’s disease testing firm C2N nabs additional $15M in financing
By LabPulse.com staff writers
C2N will allocate part of the additional financing to support its new generation blood test, PrecivityAD2, designed to aid in the diagnosis of Alzheimer's disease.
February 17, 2023
Brain Puzzle Dementia Social
Simple HealthKit closes $8M in Series A financing
By LabPulse.com staff writers
The Fremont, CA-based company said that its product portfolio includes diagnostic tests for sexual health, chronic conditions such as diabetes, and the tripledemic of COVID-19, respiratory syncytial virus (RSV), and influenza A and B.
February 6, 2023
Hands Shaking Deal Social
HTG Molecular Diagnostics prices $10M public offering
By LabPulse.com staff writers
HTG uses transcriptome-wide profiling for translational research, novel therapeutics, and clinical diagnostics across a variety of disease areas.
December 22, 2022
Gene Therapy Dna Scientist Social
Previous Page
Page 3 of 7
Next Page